Physician profile
Jan M Hoffman
NPI 1659308229
$5,251.33
in general payments reported to CMS, 2019-2025
21 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,230 · 2020: $982 · 2021: $1,262 · 2022: $228 · 2023: $177 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,165.72 | 2019-2025 | Ozempic |
| Lilly USA, LLC | $936.32 | 2019-2023 | Mounjaro |
| Abbvie INC. | $493.28 | 2019-2021 | |
| Medtronic Minimed, INC. | $461.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $302.63 | 2020-2021 | |
| Amgen INC. | $243.55 | 2021 | |
| Amarin Pharma, INC. | $228.08 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $210.49 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $208.00 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $206.65 | 2019-2021 | |
| Abbott Laboratories | $166.82 | 2021-2025 | Freestyle Libre 3 |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Esperion Therapeutics, INC. | $124.97 | 2021 | |
| Radius Health, INC. | $99.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.56 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $55.24 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $42.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.96 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $18.72 | 2019 | |
| Grt US Holding, INC. | $14.32 | 2021 | |
| Medtronic, INC. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.